Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Type of study
Language
Publication year range
1.
Endocrinol. nutr. (Ed. impr.) ; 59(4): 261-267, abr. 2012. ilus
Article in Spanish | IBECS | ID: ibc-105154

ABSTRACT

La incidencia y prevalencia de sobrepeso y obesidad ha experimentado un gran incremento en las últimas tres décadas y afecta a casi todos los países del orbe. Este fenómeno no se explica fácilmente por los cambios del estilo de vida en las distintas poblaciones con hábitos de partida muy distintos. Por lo que además del cambio del estilo de vida, otros factores empiezan a tenerse en cuenta, los llamados disruptores endocrinos y más concretamente los obesógenos. Revisamos la evidencia que existe sobre sustancias químicas que polucionan el ambiente que potencialmente puedan ser obesógenos en humanos: el dietilestilbestrol (DES), la ginesteína, el bisfenol-A, los derivados orgánicos de estaño y los ftalatos. Los tres primeros actúan principalmente sobre los receptores estrogénicos y los derivados orgánicos del estaño y los ftalatos activando los PPARγ. En conclusión, existen evidencias del efecto obesógeno de estas sustancias en estudios en animales de experimentación, tanto in vitro como in vivo, pero muy pocas en humanos. (AU)


ncidence and prevalence of owerweight and obesity have greatly increased over the past three decades in almost all countries around the world. This phenomenon is not easily explained by lifestyle changes in populations with very different initial habits. This has led to consider the influence of other factors, the so-called endocrine disruptors, and more specifically obesogens. This study reviewed the available evidence about polluting chemical substances which may potentially be obesogens in humans: DES, genistein, bisphenol A, organotins (TBT, TPT), and phthalates. The first three groups of substances mainly act upon estrogen receptors, while organotins and phthalates activate PPARγ. It was concluded that evidence exists of the obesogenic effect of these chemical substances in tissues and experimental animals, but few data are available in humans (AU)


Subject(s)
Humans , /analysis , Obesity/physiopathology , Overweight/physiopathology , PPAR gamma/pharmacokinetics , Diethylhexyl Phthalate/adverse effects , Organotin Compounds/adverse effects , Receptors, Estrogen , Diethylstilbestrol/adverse effects
2.
Endocrinol Nutr ; 59(4): 261-7, 2012 Apr.
Article in Spanish | MEDLINE | ID: mdl-22300604

ABSTRACT

Incidence and prevalence of owerweight and obesity have greatly increased over the past three decades in almost all countries around the world. This phenomenon is not easily explained by lifestyle changes in populations with very different initial habits. This has led to consider the influence of other factors, the so-called endocrine disruptors, and more specifically obesogens. This study reviewed the available evidence about polluting chemical substances which may potentially be obesogens in humans: DES, genistein, bisphenol A, organotins (TBT, TPT), and phthalates. The first three groups of substances mainly act upon estrogen receptors, while organotins and phthalates activate PPARγ. It was concluded that evidence exists of the obesogenic effect of these chemical substances in tissues and experimental animals, but few data are available in humans.


Subject(s)
Endocrine Disruptors/adverse effects , Obesity/chemically induced , Animals , Benzhydryl Compounds , Diethylstilbestrol/adverse effects , Diethylstilbestrol/pharmacology , Diethylstilbestrol/toxicity , Endocrine Disruptors/pharmacology , Endocrine Disruptors/toxicity , Endocrine System/drug effects , Energy Metabolism/drug effects , Female , Genistein/adverse effects , Genistein/pharmacology , Genistein/toxicity , Hormone Antagonists/adverse effects , Hormone Antagonists/pharmacology , Hormone Antagonists/toxicity , Humans , Male , Phenols/adverse effects , Phenols/pharmacology , Phenols/toxicity , Phthalic Acids/adverse effects , Phthalic Acids/pharmacology , Phthalic Acids/toxicity , Polycystic Ovary Syndrome/chemically induced , Pregnancy , Prenatal Exposure Delayed Effects , Receptors, Cell Surface/drug effects , Reproduction/drug effects , Trialkyltin Compounds/adverse effects , Trialkyltin Compounds/pharmacology , Trialkyltin Compounds/toxicity , Xenobiotics/adverse effects , Xenobiotics/pharmacology , Xenobiotics/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...